Intriguingly, BCL11B expression was significantly decreased in CLL patients compared with that in HIs (P = 0.008; Figure 3E, left panel), but there was no significant difference in RUNX3 between CLL patients and HIs (P = 0.898, Figure 3E, right panel). Here, BCL11B is linked to B-cell chronic lymphocytic leukemia.